Myomo stock.
The Myomo, Inc stock price gained 8.56% on the last trading day (Wednesday, 8th May 2024), rising from $3.62 to $3.93. During the last trading day the stock fluctuated 12.64% from a day low at $3.52 to a day high of $3.97. The price has been going up and down for this period, and there has been a 14.24% gain for the last 2 weeks.
Conference call begins at 4:30 p.m. Eastern time today. Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2024.MYO stock results show that Myomo met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI …Real-time Price Updates for Myomo Inc (MYO-A), along with buy or sell indicators, analysis, charts, historical performance, news and moreMyomo is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Learn more about the MyoPro product line of lightweight, non-invasive, powered arm braces that can restore function and independence for people with impaired arms and hands.
BOSTON, November 07, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from ...The Myomo, Inc. stock price is currently $ 3.75 with a total market cap valuation of $ 108.05M (28.81M shares outstanding). The Myomo, Inc. is trading on NYSE ...BOSTON, May 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological ...
Myomo Inc is listed and trades on the NYSE stock exchange. Is Myomo Inc a Good Stock to Buy? Determining whether Myomo Inc—or any stock—is a good buy requires comprehensive analysis.
In another report released yesterday, Alliance Global Partners also maintained a Buy rating on the stock with a $6.65 price target. MYO’s price has also changed dramatically for the past six ...Chg %. $3.76. -0.16. -4.08%. Myomo Inc. advanced stock charts by MarketWatch. View MYO historial stock data and compare to other stocks and exchanges.Background. Myomo ( NYSE: MYO) is an under-followed, under-owned, under-appreciated and under-valued company with extraordinary potential. I explained in my last article, in December 2023, that ...May 10, 2024 · What is Myomo's stock price target for 2024? 2 brokerages have issued 1-year price targets for Myomo's stock. Their MYO share price targets range from $6.50 to $6.50. On average, they expect the company's share price to reach $6.50 in the next year. This suggests a possible upside of 70.6% from the stock's current price.
See the company profile for Myomo, Inc. (MYO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ...
Jan 17, 2024 · Myomo (NYSE:MYO) has entered into securities purchase agreements for the purchase and sale of 1.6M shares of common stock at a price of $3.80 per share. Offering to result in total gross proceeds ...
Summary. Myomo's management has a history of diluting shareholders. The firm is still burning cash. Therefore, I will pass on this stock. Myomo claims it will become cash flow positive in Q4 by ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that on February 29, 2024, the Centers for Medicare & Medicaid Services (CMS) posted the final Medicare …Latest news about Myomo, Inc. Certain Warrants of Myomo, Inc. are subject to a Lock-Up Agreement Ending on 29-NOV-2023. -- Myomo said Monday that the Centers for Medicare & Medicaid Services have paid lump sum reimbursements to the company through their regional contractors. The company said they are beginning to...Discover Myomo's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Lead Independent Director recently bought US$175k worth of stock Mar 19. Full year 2023 earnings: EPS misses analyst expectations Mar 10. Forecast to breakeven in 2026
Discover historical prices for MYO stock on Yahoo Finance. View daily, weekly or monthly format back to when Myomo, Inc. stock was issued.© 2024 Myomo Inc. - All rights reserved. Made in the USA. Myomo, Inc. is the owner of registered trademarks Myomo and MyoPro. Terms Of Use & Privacy Policy.View the latest Myomo Inc. (MYO) stock price, news, historical charts, analyst ratings and financial information from WSJ.According to the issued ratings of 2 analysts in the last year, the consensus rating for Myomo stock is Buy based on the current 2 buy ratings for MYO. The average twelve-month price prediction for Myomo is $6.50 with a high price target of $6.50 and a low price target of $6.50. Learn more on MYO's analyst rating history.Find out all the key statistics for Myomo, Inc. (MYO), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. ... Stock Price History. Beta (5Y ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services (CMS) published a final rule classifying the MyoPro under the brace benefit category.
52 Week Low Date 05/19/23. Market Cap 104.254M. Shares Out 28.80M. 10 Day Average Volume 0.36M. Dividend -. Dividend Yield -. Beta 1.47. YTD % Change -27.35.
Detailed statistics for Myomo, Inc. (MYO) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Myomo, Inc. (MYO) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has increased by +650.98% in the last 52 weeks. The beta is 1.50, so …Find the latest analyst research for Myomo Inc. Common Stock (MYO) at Nasdaq.com.Get a real-time Myomo, Inc. (MYO) stock price quote with breaking news, financials, statistics, charts and more.Jun 14, 2021 · Myomo Inc. (NYSE:MYO) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for MYO is 51.7. Stocks with higher number ... Myomo, Inc. (MYO) delivered earnings and revenue surprises of 25.81% and 51.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?May. 8, 2024, 07:57 PM. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Myomo (NYSEMKT: MYO) just reported results for the first quarter of 2024. Myomo reported earnings per share ...BOSTON, May 08, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological ... Interactive Chart for Myomo, Inc. (MYO), analyze all the data with a huge range of indicators. Background. Myomo ( NYSE: MYO) is an under-followed, under-owned, under-appreciated and under-valued company with extraordinary potential. I explained in my last article, in December 2023, that ...Find the latest Myomo, Inc. (MYO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Annual Report 2022. Annual Report 2021. Annual Report 2021. Annual Report 2020. Annual Report 2020. Annual Report 2019. Annual Report 2019. Results and Presentations.
Medical Products Manufacturing. $0.110B. $0.019B. Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro (R) product line of lightweight, non-invasive, powered arm braces to restore function in the ...
Our analysts predict Myomo Inc ( MYO) to change +1280.89% by 2045, soaring from $50.26 to an average price of $50.26, potentially reaching $51.21. While $50.26 is the low estimate, the potential upside is significant. Myomo Inc ( MYO) stock is expected to climb by 2050, reaching an average of $77.30, a +2023.75% change from its current level.A high-level overview of Myomo, Inc. (MYO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.In depth view into MYO (Myomo) stock including the latest price, news, dividend history, earnings information and financials. ... Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered ... View the latest Myomo Inc. (MYO) stock price, news, historical charts, analyst ratings and financial information from WSJ. View the latest Myomo Inc. (MYO) stock price, news, historical charts, analyst ratings and financial information from WSJ. A list of analyst ratings for Myomo (MYO) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.If you are looking for stocks that are well positioned to maintain their recent uptrend, Myomo, Inc. (MYO) could be a great choice. It is one of the several stocks that passed through our "Recent ... Myomo, Inc. (AMEX:MYO) Q1 2024 Earnings Call Transcript. Find the latest Myomo, Inc. (MYO) stock quote, history, news and other vital information to help you with your stock trading and investing. Open 3.8900. Bid 3.6000 x 2900. Ask 3.6700 x 1000. Day's Range 3.6200 - 3.9927. 52 Week Range 0.3710 - 5.5800. Volume 89,060. Avg. Volume 281,275. Market Cap (intraday) 104.83M. Beta (5Y Monthly)...
Myomo, Inc. (NYSE American: MYO) reports Q4 total revenue of $4.8 million, up 18% from the prior year. The addition of Medicare Part B patients leads to a record 183 MyoPro orders, up 87%. ... Preferred stock — — Common stock 2,715 775 Additional paid-in capital 105,840,239 95,105,071 Accumulated other comprehensive income 83,669 ...Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its "best efforts" public offering of 20,000,000 shares of common stock (or common stock …ACTIVE/127239888.2 Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market BOSTON (January 19, 2024) ─ Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for thoseInstagram:https://instagram. mapa mta nycsmart remote controltracker cell phone numberfox sports espanol View today's Myomo Inc stock price and latest MYO news and analysis. Create real-time notifications to follow any changes in the live stock price.Jun 12, 2017 · Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm ... calculator ten keymyarc chart Unexchanged or unsurrendered stocks are those shares that should have changed hands but have not. When a share goes unexchanged, it is typically the fault of the company issuing th... make an emoji of yourself 7 Mar 2024 ... Net loss for the fourth quarter of 2023 was $2.5 million , or $0.07 per share, compared with a net loss of $2.2 million , or $0.29 per share, ...Myomo Inc has a consensus price target of $5.07, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Maxim Group, and ...Press Release. Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market. BOSTON (January 17, 2024) ─ Myomo, Inc. (NYSE American: MYO) (“ Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper …